THE BOARD OF DIRECTORS Steven XuChairman Steven is a Chartered Accountant (CA ANZ) with over 15 years’ experience working in PricewaterhouseCoopers and listed companies in Australia and China. He specialises in financing, IPO and M&A activities in a broad range of sectors including technology, agriculture, smart manufacturing and healthcare. Steven is the head of the MY INP Venture Capital Fund with global investments in Medicinal Cannabis and related industry companies. He has strong international connections, especially in North America, Israel and China, and continues to analyse and seek out investment opportunities in these industry sectors. Alan BeasleyNon Executive Director Alan has worked in the Investment Banking and Investment Management industries for over 30 years, with Bankers Trust Australia, Goldman Sachs Asset Management, and BNP Paribas Asset Management Ltd - the last two positions as Managing Director and Australian Country Head. Alan is a director and former director of several listed and unlisted public and private companies. Alan graduated with a Bachelor of Economics, (UNE) and completed an Advanced Management Program in International Investment Management, from the Graduate Business School, Stanford University, USA. Alan is a Certified Practising Accountant, (CPA) Fellow of the Governance Institute of Australia, (FGIA) and Fellow of the Australian Institute of Company Directors (FAICD). Lou CattelanNon Executive Director Lou has over 30 years’ experience in Pharmaceutical, Nutraceutical, Complementary Healthcare and allied industry sectors. He specialises in Project Management, Operations, Quality Assurance, Supply Chain, Strategic Planning, New Product Development, Regulatory Compliance(TGA & FDA), Sales & Marketing, Business Development and Special Projects. Lou sat on the ASMI (Australian Self Medication Industry – which is the peak industry Body for Australian Pharmaceuticals) Committee for Complementary Medicines to act as a liaison between TGA and key industry stakeholders. Lou is currently a Director of Contract Pharmaceutical Services of Australia (CPSA) as well as their Sales & Marketing Director. During his 17 years at CPSA he has consulted with all major Pharma companies including Pfizer, MSD, Mylan and GSK to take innovative concepts through to compliant finished products. He has also worked in senior hands-on positions with Ella Bache, Milpharma, Sunspot Products, Bayer Pharma and Blackmores. Gary RadcliffNon Executive Director Gary is a practicing Barrister, having been called to the Bar in 1984 and is the President of the Gold Coast Bar Association. Gary is also a specialist adjudicator in relation to Dispute Resolution recognised by the Office of the Commissioner for Body Corporate and Community Management (Queensland, Australia). Gary provides a wealth of experience in corporate governance and compliance matters in both Australia and internationally. In addition to his legal practice, Gary has significant experience in project management, corporate advisory and company directorship in a wide range of sectors, most notably; pharmaceuticals, financial services and technology.Company Secretary Henry KinstlingerCompany Secretary Henry Kinstlinger has in the past thirty years been actively involved in the financial and corporate management of several public companies and non-governmental organisations. He is a professional company secretary and corporate consultant with broad experience in investor and community relations and corporate and statutory compliance.